🟢 United Therapeutics is trading 5.7% up in pre-market as XBI gains 3.64%

United Therapeutics is trading at $585.27, up 5.67%, in line with the supplied pre-market biotech rally, with XBI up 3.64%.

• On October 20, the company said it opened a third pathogen-free xenograft production facility, expanding organ-manufacturing capacity.
• On October 19, it announced FDA clearance for its SUMMIT clinical trial; available reporting does not directly link either announcement to this morning’s price move.
• No pre-market volume data was available in the reviewed sources.